ラティス（ビマトプロスト）の世界市場レポート2020

• 英文タイトル：Covid-19 Impact on Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Report 2020

• レポートコード：20QY06-04253 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：化学・材料

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、ラティス（ビマトプロスト）のグローバル市場について種類別（医薬品用、化粧品用）、用途別（薬、化粧品、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ラティス（ビマトプロスト）市場の概要 ・世界の主要地域別ラティス（ビマトプロスト）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のラティス（ビマトプロスト）市場規模2015-2026：種類別（医薬品用、化粧品用） ・世界のラティス（ビマトプロスト）市場規模2015-2026：用途別（薬、化粧品、その他） ・ラティス（ビマトプロスト）の北米市場規模2015-2020 ・ラティス（ビマトプロスト）のヨーロッパ市場規模2015-2020 ・ラティス（ビマトプロスト）の中国市場規模2015-2020 ・ラティス（ビマトプロスト）の日本市場規模2015-2020 ・ラティス（ビマトプロスト）の東南アジア市場規模2015-2020 ・ラティス（ビマトプロスト）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Allergan plc (AbbVie Inc.)、Sandoz(Novartis)、Hi-Tech Pharmacal、Apotex Inc.） ・ラティス（ビマトプロスト）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ラティス（ビマトプロスト）の市場動向・機会・課題 ・調査の結論

A recently published report by QY Research titled Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Latisse (Bimatoprost) ( CAS 155206-00-1) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Bimatoprost is a medication used to treat high pressure inside the eye including glaucoma.Specifically it is used for open angle glaucoma when other agents are not sufficient.It may also be used to increase the size of the eyelashes. It is used as an eye drop.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Latisse (Bimatoprost) ( CAS 155206-00-1) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Latisse (Bimatoprost) ( CAS 155206-00-1) industry.
Based on our recent survey, we have several different scenarios about the Latisse (Bimatoprost) ( CAS 155206-00-1) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Latisse (Bimatoprost) ( CAS 155206-00-1) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Latisse (Bimatoprost) ( CAS 155206-00-1) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Latisse (Bimatoprost) ( CAS 155206-00-1) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Latisse (Bimatoprost) ( CAS 155206-00-1) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Latisse (Bimatoprost) ( CAS 155206-00-1) market. The report also includes nautical information, where it shows Latisse (Bimatoprost) ( CAS 155206-00-1) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Latisse (Bimatoprost) ( CAS 155206-00-1) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Latisse (Bimatoprost) ( CAS 155206-00-1) market.
Geographical Analysis:
Based on region, the global Latisse (Bimatoprost) ( CAS 155206-00-1) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Latisse (Bimatoprost) ( CAS 155206-00-1) market are
Allergan plc (AbbVie Inc.)
Sandoz(Novartis)
Hi-Tech Pharmacal
Apotex Inc.
…
Segment by Type
Medicine Grade
Cosmetic Grade
Segment by Application
Medicine
Cosmetic
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Latisse (Bimatoprost) ( CAS 155206-00-1) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Latisse (Bimatoprost) ( CAS 155206-00-1) market.
• The market share of the global Latisse (Bimatoprost) ( CAS 155206-00-1) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Latisse (Bimatoprost) ( CAS 155206-00-1) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Latisse (Bimatoprost) ( CAS 155206-00-1) market.

レポート目次

---

1 Latisse (Bimatoprost) ( CAS 155206-00-1) Market Overview
1.1 Latisse (Bimatoprost) ( CAS 155206-00-1) Product Scope
1.2 Latisse (Bimatoprost) ( CAS 155206-00-1) Segment by Type
1.2.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type (2020-2026)
1.2.2 Medicine Grade
1.2.3 Cosmetic Grade
1.3 Latisse (Bimatoprost) ( CAS 155206-00-1) Segment by Application
1.3.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Comparison by Application (2020-2026)
1.3.2 Medicine
1.3.3 Cosmetic
1.3.4 Others
1.4 Latisse (Bimatoprost) ( CAS 155206-00-1) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2015-2026)
1.4.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue and Growth Rate (2015-2026)
1.4.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Latisse (Bimatoprost) ( CAS 155206-00-1) Industry Impact
1.5.1 How the Covid-19 is Affecting the Latisse (Bimatoprost) ( CAS 155206-00-1) Industry
1.5.1.1 Latisse (Bimatoprost) ( CAS 155206-00-1) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Latisse (Bimatoprost) ( CAS 155206-00-1) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Latisse (Bimatoprost) ( CAS 155206-00-1) Players to Combat Covid-19 Impact

2 Latisse (Bimatoprost) ( CAS 155206-00-1) Estimate and Forecast by Region
2.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Region (2015-2020)
2.2.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Region (2015-2020)
2.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Latisse (Bimatoprost) ( CAS 155206-00-1) Estimates and Projections (2015-2026)
2.4.2 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Estimates and Projections (2015-2026)
2.4.3 China Latisse (Bimatoprost) ( CAS 155206-00-1) Estimates and Projections (2015-2026)
2.4.4 Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Estimates and Projections (2015-2026)
2.4.6 India Latisse (Bimatoprost) ( CAS 155206-00-1) Estimates and Projections (2015-2026)
3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Competition Landscape by Players
3.1 Global Top Latisse (Bimatoprost) ( CAS 155206-00-1) Players by Sales (2015-2020)
3.2 Global Top Latisse (Bimatoprost) ( CAS 155206-00-1) Players by Revenue (2015-2020)
3.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Latisse (Bimatoprost) ( CAS 155206-00-1) as of 2019)
3.4 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Average Price by Company (2015-2020)
3.5 Manufacturers Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Latisse (Bimatoprost) ( CAS 155206-00-1) Players (Opinion Leaders)
4 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size by Type
4.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Historic Market Review by Type (2015-2020)
4.1.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
4.1.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Type (2015-2020)
4.1.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price by Type (2014-2020)
4.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Type (2021-2026)
4.2.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Type (2021-2026)
4.2.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price Forecast by Type (2021-2026)
5 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size by Application
5.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Historic Market Review by Application (2015-2020)
5.1.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2015-2020)
5.1.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Application (2015-2020)
5.1.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price by Application (2015-2020)
5.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Application (2021-2026)
5.2.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Application (2021-2026)
5.2.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price Forecast by Application (2021-2026)

3 North America Latisse (Bimatoprost) ( CAS 155206-00-1) Market Facts & Figures
3.2 North America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2015-2020)
3.3 North America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
3.4 North America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2015-2020)

4 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Market Facts & Figures
4.2 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2015-2020)
4.3 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
4.4 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2015-2020)

5 China Latisse (Bimatoprost) ( CAS 155206-00-1) Market Facts & Figures
5.2 China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2015-2020)
5.3 China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
5.4 China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2015-2020)

6 Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Market Facts & Figures
6.2 Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2015-2020)
6.3 Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
6.4 Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2015-2020)

7 Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Market Facts & Figures
7.2 Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2015-2020)

8 India Latisse (Bimatoprost) ( CAS 155206-00-1) Market Facts & Figures
8.2 India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2015-2020)
8.3 India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
8.4 India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Latisse (Bimatoprost) ( CAS 155206-00-1) Business
12.1 Allergan plc (AbbVie Inc.)
12.1.1 Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Corporation Information
12.1.2 Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Business Overview and Total Revenue
12.1.3 Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Products Offered
12.1.5 Allergan plc (AbbVie Inc.) Recent Development
12.2 Sandoz(Novartis)
12.2.1 Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Corporation Information
12.2.2 Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Business Overview and Total Revenue
12.2.3 Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Products Offered
12.2.5 Sandoz(Novartis) Recent Development
12.3 Hi-Tech Pharmacal
12.3.1 Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Corporation Information
12.3.2 Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Business Overview and Total Revenue
12.3.3 Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Products Offered
12.3.5 Hi-Tech Pharmacal Recent Development
12.4 Apotex Inc.
12.4.1 Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Corporation Information
12.4.2 Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Business Overview and Total Revenue
12.4.3 Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Products Offered
12.4.5 Apotex Inc. Recent Development
…

13 Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturing Cost Analysis
13.1 Latisse (Bimatoprost) ( CAS 155206-00-1) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Latisse (Bimatoprost) ( CAS 155206-00-1)
13.4 Latisse (Bimatoprost) ( CAS 155206-00-1) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Latisse (Bimatoprost) ( CAS 155206-00-1) Distributors List
14.3 Latisse (Bimatoprost) ( CAS 155206-00-1) Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) Growth Rate by Type (2020-2026)
Table 2. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Latisse (Bimatoprost) ( CAS 155206-00-1) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Latisse (Bimatoprost) ( CAS 155206-00-1) Players to Combat Covid-19 Impact
Table 8. Global Market Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Region (2015-2020)
Table 10. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Region (2015-2020)
Table 11. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Region (2015-2020)
Table 13. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) Forecast by Region (2021-2026)
Table 14. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Latisse (Bimatoprost) ( CAS 155206-00-1) (Kiloton) of Key Companies (2015-2020)
Table 18. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Company (2015-2020)
Table 19. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Company (2015-2020)
Table 21. Global Latisse (Bimatoprost) ( CAS 155206-00-1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Latisse (Bimatoprost) ( CAS 155206-00-1) as of 2019)
Table 22. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Average Price (US$/Ton) of Key Company (2015-2020)
Table 23. Manufacturers Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturing Sites and Area Served
Table 24. Manufacturers Latisse (Bimatoprost) ( CAS 155206-00-1) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Latisse (Bimatoprost) ( CAS 155206-00-1) Players
Table 27. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Type (2015-2020)
Table 28. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Type (2015-2020)
Table 29. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price (Kiloton) by Type (2015-2020)
Table 31. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Type (2021-2026)
Table 32. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Type (2021-2026)
Table 34. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price (Kiloton) by Type (2021-2026)
Table 35. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Application (2015-2020)
Table 36. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Application (2015-2020)
Table 37. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price (Kiloton) by Application (2015-2020)
Table 39. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Application (2021-2026)
Table 40. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Application (2021-2026)
Table 41. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Application (2021-2026)
Table 43. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price (Kiloton) by Application (2021-2026)
Table 44. United States Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Company (2015-2020)
Table 45. United States Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2015-2020)
Table 46. United States Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Type (2015-2020)
Table 47. United States Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
Table 48. United States Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Application (2015-2020)
Table 49. United States Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2015-2020)
Table 50. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Company (2015-2020)
Table 51. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2015-2020)
Table 52. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Type (2015-2020)
Table 53. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
Table 54. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Application (2015-2020)
Table 55. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
Table 56. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Company (2015-2020)
Table 57. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2015-2020)
Table 58. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Type (2015-2020)
Table 59. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
Table 60. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Application (2015-2020)
Table 61. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2015-2020)
Table 62. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Company (2015-2020)
Table 63. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2015-2020)
Table 64. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Type (2015-2020)
Table 65. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
Table 66. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Application (2015-2020)
Table 67. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Company (2015-2020)
Table 69. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Type (2015-2020)
Table 71. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Type (2015-2020)
Table 73. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2015-2020)
Table 74. India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Company (2015-2020)
Table 75. India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2015-2020)
Table 76. India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Type (2015-2020)
Table 77. India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2015-2020)
Table 78. India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Application (2015-2020)
Table 79. India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2015-2020)
Table 80. Allergan plc (AbbVie Inc.) Corporation Information
Table 81. Allergan plc (AbbVie Inc.) Description and Business Overview
Table 82. Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 83. Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Product
Table 84. Allergan plc (AbbVie Inc.) Recent Development
Table 85. Sandoz(Novartis) Corporation Information
Table 86. Sandoz(Novartis) Description and Business Overview
Table 87. Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 88. Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Product
Table 89. Sandoz(Novartis) Recent Development
Table 90. Hi-Tech Pharmacal Corporation Information
Table 91. Hi-Tech Pharmacal Description and Business Overview
Table 92. Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table 93. Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Product
Table 94. Hi-Tech Pharmacal Recent Development
Table . Apotex Inc. Corporation Information
Table . Apotex Inc. Description and Business Overview
Table . Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2015-2020)
Table . Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Product
Table . Apotex Inc. Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Latisse (Bimatoprost) ( CAS 155206-00-1) Distributors List
Table 103. Latisse (Bimatoprost) ( CAS 155206-00-1) Customers List
Table 104. Market Key Trends
Table 105. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 106. Key Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Latisse (Bimatoprost) ( CAS 155206-00-1) Product Picture
Figure 2. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Share by Application in 2020 & 2026
Figure 6. Medicine Examples
Figure 7. Cosmetic Examples
Figure 8. Others Examples
Figure 9. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) Growth Rate (2015-2026)
Figure 10. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price Trends Growth Rate (2015-2026) (US$/Ton)
Figure 12. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) Growth Rate (2015-2026)
Figure 16. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Latisse (Bimatoprost) ( CAS 155206-00-1) Players Market Share by Revenue in Latisse (Bimatoprost) ( CAS 155206-00-1) 2015 & 2019
Figure 27. Latisse (Bimatoprost) ( CAS 155206-00-1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Type (2015-2020)
Figure 29. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Application (2015-2020)
Figure 31. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type in 2019
Figure 33. United States Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type in 2019
Figure 34. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company in 2019
Figure 35. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type in 2019
Figure 36. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application in 2019
Figure 37. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company in 2019
Figure 38. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type in 2019
Figure 39. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application in 2019
Figure 40. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company in 2019
Figure 41. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type in 2019
Figure 42. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application in 2019
Figure 46. India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company in 2019
Figure 47. India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type in 2019
Figure 48. India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application in 2019
Figure 49. Allergan plc (AbbVie Inc.) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sandoz(Novartis) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Hi-Tech Pharmacal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Apotex Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Latisse (Bimatoprost) ( CAS 155206-00-1)
Figure 55. Manufacturing Process Analysis of Latisse (Bimatoprost) ( CAS 155206-00-1)
Figure 56. Latisse (Bimatoprost) ( CAS 155206-00-1) Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Porter's Five Forces Analysis
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

---